Literature DB >> 2450703

A monocyte chemotaxis inhibiting factor in serum of HIV infected men shares epitopes with the HIV transmembrane protein gp41.

M Tas1, H A Drexhage, J Goudsmit.   

Abstract

This report describes that gp41, the transmembranous envelope protein of HIV, is able to inhibit monocyte chemotaxis (measured as FMLP-induced polarization). To study the presence of such immunosuppressive HIV env proteins in the circulation of HIV-infected men, fractions were prepared from serum via ultrafiltration, yielding molecules with a relative Mr of 25-50. These fractions inhibited FMLP-induced polarization of normal human monocytes, while similar fractions of HIV-uninfected men did not. A monoclonal antibody (MoAb) to gp41 was able to adsorb the serum factor responsible for this inhibitory activity. This demonstration of the presence of a gp41-like factor in the circulation of HIV-infected men exerting immunosuppressive activities might have implications for the understanding of the pathogenesis of AIDS, as well as for the selection of HIV-encoded proteins for putative vaccines.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450703      PMCID: PMC1541623     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis.

Authors:  G Poli; B Bottazzi; R Acero; L Bersani; V Rossi; M Introna; A Lazzarin; M Galli; A Mantovani
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

2.  Lymphocyte-reactive antibodies in acquired immune deficiency syndrome.

Authors:  R C Williams; H Masur; T J Spira
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

3.  Thymic dysplasia in acquired immunodeficiency syndrome.

Authors:  R Elie; A C Laroche; E Arnoux; J M Guérin; G Pierre; R Malebranche; T A Seemayer; J M Dupuy; P Russo; W S Lapp
Journal:  N Engl J Med       Date:  1983-04-07       Impact factor: 91.245

4.  The syndrome of Kaposi's sarcoma and opportunistic infections: an epidemiologically restricted disorder of immunoregulation.

Authors:  A S Fauci
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

5.  Monocyte responsiveness to chemotactic stimuli is a property of a subpopulation of cells that can respond to multiple chemoattractants.

Authors:  G J Cianciolo; R Snyderman
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

6.  Mononuclear phagocyte function in head and neck cancer: depression of murine macrophage accumulation by low molecular weight factors derived from head and neck carcinomas.

Authors:  F J Balm; B M von Blomberg-van deFlier; H A Drexhage; M de Haan-Meulman; G B Snow
Journal:  Laryngoscope       Date:  1984-02       Impact factor: 3.325

7.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

8.  Endothelial injury and regeneration. IV. Endotoxin: a nondenuding injury to aortic endothelium.

Authors:  M A Reidy; S M Schwartz
Journal:  Lab Invest       Date:  1983-01       Impact factor: 5.662

Review 9.  Autopsy pathology in the acquired immune deficiency syndrome.

Authors:  C M Reichert; T J O'Leary; D L Levens; C R Simrell; A M Macher
Journal:  Am J Pathol       Date:  1983-09       Impact factor: 4.307

10.  The mechanism of retrovirus suppression of human T cell proliferation in vitro.

Authors:  E A Copelan; J J Rinehart; M Lewis; L Mathes; R Olsen; A Sagone
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

View more
  7 in total

1.  HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation.

Authors:  Francisco J Quintana; Doron Gerber; Sally C Kent; Irun R Cohen; Yechiel Shai
Journal:  J Clin Invest       Date:  2005-07-07       Impact factor: 14.808

2.  Beneficial effects of the thymic hormone preparation thymostimulin in patients with defects in cell-mediated immunity and chronic purulent rhinosinusitis. A double-blind cross-over trial on improvements in monocyte polarization and clinical effects.

Authors:  M Tas; J A Leezenberg; H A Drexhage
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

3.  Decreased Fc receptor expression on innate immune cells is associated with impaired antibody-mediated cellular phagocytic activity in chronically HIV-1 infected individuals.

Authors:  Anne-Sophie Dugast; Andrew Tonelli; Christoph T Berger; Margaret E Ackerman; Gaia Sciaranghella; Qingquan Liu; Magdalena Sips; Ildiko Toth; Alicja Piechocka-Trocha; Musie Ghebremichael; Galit Alter
Journal:  Virology       Date:  2011-05-12       Impact factor: 3.616

4.  Abnormal monocyte chemotaxis in patients with chronic purulent rhinosinusitis: an effect of retroviral p15E-related factors in serum.

Authors:  E M van de Plassche-Boers; M Tas; M de Haan-Meulman; M Kleingeld; H A Drexhage
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

Review 5.  Opportunities to exploit non-neutralizing HIV-specific antibody activity.

Authors:  Margaret E Ackerman; Galit Alter
Journal:  Curr HIV Res       Date:  2013-07       Impact factor: 1.581

6.  Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1.

Authors:  C L Ruegg; C R Monell; M Strand
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

7.  Serum suppressive activity of HIV seropositive patients.

Authors:  D Israel-Biet; M Ekwalanga; A Venet; P Even; J M Andrieu
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.